Characterization and downstream processing of HIV-1 core and virus-like- particles produced in serum free medium

Enzyme and Microbial Technology

Volumn 26, Issue 1, 2000, Pages 61-70

  Cruz, Pedro E ^a   Peixoto, Cristina C ^a   Devos, Kathleen ^b   Moreira, José L ^a   Saman, Eric ^b   Carrondo, Manuel J T ^a,c  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b INNOGENETICS   (Belgium)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Characterization; HIV 1; Insect cells; Purification; Virus like particles

Indexed keywords

CENTRIFUGATION; CHROMATOGRAPHY; CLARIFICATION; DENSITY (SPECIFIC GRAVITY); MICROFILTRATION; MOLECULAR WEIGHT; PURIFICATION; ULTRAFILTRATION; VIRUSES;

GEL FILTRATION CHROMATOGRAPHY; VIRUS-LIKE PARTICLES; WESTERN IMMUNOBLOT;

BIOTECHNOLOGY;

CORE PROTEIN;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REACTION ANALYSIS; STRUCTURE ANALYSIS; VIRUS PARTICLE;

EID: 0033957760     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-0229(99)00128-3     Document Type: Article

References (45)

1. Griffiths J.C., Harris S.J., Layton G.T., Berrie E.L., French T.J., Burns N.R., Adams S.E., Kingsman A.J. Hybrid human immunodeficiency virus gag particles as an antigen carrier system induction of cytotoxic T-cell and humoral responses by a gag: V3 fusion . J Virol. 67:1993;3191-3198.
2. gag particles produced in baculovirus infected insect cells. J Chem Technol Biotechnol. 72:1998;149-158.
3. Cruz P.E., Cunha A., Peixoto C., Clemente J., Moreira J., Carrondo M.J.T. Optimization of the production of virus like particles in insect cells. Biotechnol Bioeng. 60:1998;408-418.
4. Volpers C., Schirmacher P., Streeck R.E., Sapp M. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology. 200:1994;504-512.
5. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfeld S., Anderson L.J., Shimada T., Young N.S. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci. 88:1991;4646-4650.
6. Zhao Y., Jones I.M., Hockley D.J., Nermut M.V., Roy P. Complementation of human immunodeficiency virus (HIV-1) gag particle formation. Virology. 199:1994;403-408.
7. Roy P., Bishop D.H.L., LeBlois H., Erasmus B.J. Long lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles evidence for homologous and partial heterologous protection . Vaccine. 12:1994;805-811.
8. Yamshchikov G.V., Ritter G.D., Vey M., Compans R.W. Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system. Virology. 214:1995;50-58.
9. Rasmussen L., Battles J.K., Ennis W.H., Nagashima K., Gonda M.A. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology. 178:1990;435-451.
10. Rovinsky B., Haynes J.R., Cao S.X., James O., Sia C., Zolla-Pazner S., Matthews T.J., Klein M.H. Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins implications for development of a cross-protective AIDS vaccine . J Virol. 66:1992;4003-4012.
11. Fu J., VanDusen W.J., Kolodin D.G., O'Keefe D.O., Herber W.K., George H.A. Continuous culture study of the expression of Hepatitis B surface antigen and its self-assembly into virus-like particles in Saccharomyces cerevisiae. Biotechnol Bioeng. 49:1996;578-586.
12. Murphey-Corb M., Martin L.N., Davison-Fairburn B., Monelaro R.C., Miller M., West M., Ohkawa S., Baskin G.B., Zhang J.Y., Putney S.D., Allison A.C., Eppstein D.A. A Formalin-inactivated whole SIV vaccine confers protection in Macaques. Science. 246:1989;1293-1297.
13. Sutjipto S., Pedersen N.C., Miller C.J., Gardner M.B., Hanson C.V., Gettie A., Jennings M., Higgins J., Marx P.A. Inactivated simian immunodeficiency virus vaccine failed to protect Rhesus Macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol. 64:1990;2290-2297.
14. Warren R.Q., Wolf H., Stunz G.W., Kennedy R.C. Antibody reactivity to synthetic peptides representing the principal neutralizing determinant of HIV-1 in mouse strains following repeated immunization with recombinant gp160. Exp Clinical Immunogenetics. 10:1993;168-175.
15. el-Amad Z., Murthy K.K., Higgins K., Cobb E.K., Haigwood N.L., Levy J.A., Steimer K.S. Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. AIDS. 9:1995;1313-1322.
16. Yu S.L., Chou M.J., Tam M.F., Lee T.H., Syu W.J. Expression and antigenicity of human immunodeficiency virus type-1 transmembrane protein gp41 in insect cells. Biochem Biophys Res Commun. 191:1993;207-213.
17. Pincus S.H., Messer K.G., Schwartz D.H., Lewis G.K., Graham B.S., Blattner W.A., Fisher G. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccines. J Clinical Investigation. 91:1993;1987-1996.
18. Keefer M.C., Graham B.S., Belshe R.B., Schwartz D., Corey L., Bolognesi D.P., Stablein D.M., Montefiori D.C., McElrath M.J., Clements M.L. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS vaccine clinical trials network. AIDS Res Human Retroviruses. 10:1994;1713-1723.
19. Luo L., Li Y., Cannon P.M., Kim S., Kang C.Y. Chimeric gag-V3 virus-like particles of immunodeficiency virus induce virus-neutralizing antibodies. Proc Natl Acad Sci. 89:1992;10527-10531.
20. Wagner R., Fliessbach H., Wanner G., Motz M., Niedrig M., Deby G., von Brunn A., Wolf H. Studies on processing, particle formation, and immunogeniciy of the HIV-1 gag gene product a possible component of a HIV vaccine . Arch Virol. 127:1992;117-137.
21. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski A.J., Whitehorn E.A., Baumeister K., Ivanoff L., Petteway S.R., Pearson M., Lautenberger J.A., Papas T.S., Ghrayeb J., Chang N.T., Gallo R.C., Wong-Stall F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
22. Mervis R.J., Ahmad N., Lillehoj E.P., Raum M.G., Salazar R.F.H., Chan H.W., Capon D.J. The gag gene products of human immunodeficiency virus type 1 alignement within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors . J Virol. 62:1988;3993-4002.
23. Allan J.S., Coligan J.E., Barin F., McLane M.F., Sodroski J.G., Rose C.A., Haseltine W.A., Lee T.H., Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 228:1985;1091-1094.
24. Robey W.G., Satai B., Oroszlan S., Arthur L.O., Gonda M.A., Gallo R.C., Fischinger P.J. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science. 228:1985;583-595.
25. Vzorov A.N., Bukrinsky M.I., Grigoriev V.B., Tentsov Y., Bukrinskaya A.G. Highly immunogenic human immunodeficiency virus-like particles are produced by recombinant vaccinia virus-infected cells. AIDS Res Human Retroviruses. 7:1991;29-36.
26. Cruz P.E., Moreira J.L., Carrondo M.J.T. Insect cell growth evaluation during serum-free adaptation in stirred suspension cultures. Biotechnol Techniques. 11:1997;117-120.
27. King LA, Possee RD. The Baculovirus Expression System. London, Chapman & Hall:1987.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Cruz P.E., Martins P.C., Alves P.M., Peixoto C.C., Santos H., Moreira J.L., Carrondo M.J.T. Proteolytic activity in infected and non-infected insect cells degradation of HIV-1 Pr55gag particles . Biotechnol Bioeng. 65:1999;133-143.
30. max testing for practical microfiltration train scale-up in biopharmaceutical processing. Pharmaceutical Technology 1995, September, 64-76.
31. Licari P., Bailey J.E. Factors influencing recombinant protein yields in an insect cell-baculovirus expression system multiplicity of infection and intracellular product degradation . Biotechnol Bioeng. 37:1991;238-246.
32. Tomley F.M., Armstrong S.J., Owen L.N. Reverse transcriptase activity in a case of ovine lymphoblastic leukaemia. Res Veterinary Science. 34:1983;50-54.
33. Dinowitz M., Lie Y.S., Low M.A., Lazar R., Fautz C., Potts B., Sernatinger J., Anderson K. Recent studies on retrovirus-like particles in Chinese hamster ovary cells. Develop Biol Stand. 76:1992;201-207.
34. Petry H., Petry K., Schmidt M., Hunsmann G., Anders F., Luke W. Isolation and characterization of a retrovirus from the fish genus Xiphophorus. Virology. 188:1992;785-792.
35. Burtonboy G., Delferriere N., Mousset B., Heusterspreute M. Isolation of a C-type retrovirus from an HIV infected cell line. Arch Virol. 130:1993;289-300.
36. Eaton W.D., Folkins B., Bagshaw J., Traxler G., Kent M.L. Isolation of a retrovirus from two fish cell lines developed from chinook salmon (Oncorhynchus tshawytscha) with plasmacytoid leukaemia. J Gen Virol. 74:1993;2299-2302.
37. Lauharanta J. Ultrastructure of cultured mouse S91 melanoma cells with special emphasis on viral particles. Arch Dermatology Res. 281:1989;284-287.
38. Frerichs G.N., Morgan D., Hart D., Skerrow C., Roberts R.J., Onions D.E. Spontaneously productive C-type retrovirus infection of fish cell lines. J Gen Virol. 72:1991;2537-2579.
39. Kertayadnya G., Wilcox G.E., Soeharsono S., Hartaningsih N., Coelen R.J., Cook R.D., Collins M.E., Browlie J. Characteristics of a retrovirus associated with Jembrana disease in Bali cattle. J Gen Virol. 74:1993;1765-1778.
40. Mathes L.E., Yohn D.S., Olsen R.G. Purification of infectious feline leukemia virus from large volumes of tissue culture fluids. J Clinical Microbiol. 5:1977;372-374.
41. Schwab K., De Leon R., Sobsey M. Concentration and purification of beef extract mock eluates from water samples for the detection of enteroviruses, Hepatitis A virus, and Norwalk virus by reverse transcription PCR. Appl Environmental Microbiol. 61:1995;531-537.
42. Bowles N., Eisensmith R., Mohuiddin R., Pyron M., Woo S. A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Human Gene Therapy. 7:1996;1735-1742.
43. Lee S.-G., Kim S., Robbins P.D., Kim B.-G. Optimization of environmental factors for the production and handling of recombinant retrovirus. Appl Microbiol Biotechnol. 45:1996;477-483.
44. Miller D.L., Meikle P.J., Anson D.S. A rapid and efficient method for concentration of small volumes of retroviral supernatant. Nucleic Acids Res. 24:1996;1576-1577.
45. Prior C., Bay P., Ebert B., Gore R., Holt J., Irish T., Jensen F., Leone C., Mitschelen J., Stiglitz M., Tarr C., Trauger R.J., Weber D., Hrinda M. Process development for the manufacture of inactivated HIV-1. Pharmaceutical Technol. 19:1995;30-52.